Global Incidence and Prevalence of Gaucher Disease: A Targeted Literature Review
Open Access
- 22 December 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (1) , 85
Abstract
Incidence and prevalence estimates for Gaucher disease (GD) are scarce for this rare disease and can be variable within the same region. This review provides a qualitative synthesis of global GD incidence and prevalence estimates, GD1–3 type-specific and overall, published in the last 10 years. A targeted literature search was conducted across multiple databases from January 2011 to September 2020, including web-based sources and congress proceedings to May 2021. Searches yielded 490 publications, with 31 analyzed: 20 cohort studies (15 prospective, 5 retrospective), 6 cross-sectional studies, 5 online reports (most from Europe (n = 11) or North America (n = 11); one multiregional). Across all GD types, incidence estimates ranged 0.45–25.0/100,000 live births (16 studies), lowest for Asia-Pacific. Incidence of GD1: 0.45–22.9/100,000 live births (Europe and North America) and GD3: 1.36/100,000 live births (Asia-Pacific only). GD type-specific prevalence estimates per 100,000 population were GD1: 0.26–0.63; GD2 and GD3: 0.02–0.08 (Europe only); estimates for GD type unspecified or overall ranged 0.11–139.0/100,000 inhabitants (17 studies), highest for North America. Generalizability was assessed as “adequate”or “intermediate” for all regions with data. GD incidence and prevalence estimates for the last 10 years varied considerably between regions and were poorly documented outside Europe and North America. Data for GD2 and GD3 were limited.Keywords
Funding Information
- Takeda Development Center Americas, Inc.
This publication has 61 references indexed in Scilit:
- Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 studyAmerican Journal of Hematology, 2013
- Newborn Screening for Lysosomal Storage Disorders in Hungary2012
- A Pilot Newborn Screening Program for Lysosomal Storage Disorders (LSD) in IllinoisMolecular Genetics and Metabolism, 2012
- The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patientsOrphanet Journal of Rare Diseases, 2012
- Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian PeninsulaOrphanet Journal of Rare Diseases, 2012
- Expanding newborn screening for lysosomal disorders: Opportunities and challengesDevelopmental Disabilities Research Reviews, 2011
- A reappraisal of Gaucher disease—diagnosis and disease management algorithmsAmerican Journal of Hematology, 2010
- Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosisBritish Journal of Haematology, 2009
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)Human Mutation, 2008
- Consequences of diagnostic delays in type 1 Gaucher disease: The need for greater awareness among Hematologists–Oncologists and an opportunity for early diagnosis and interventionAmerican Journal of Hematology, 2007